{"transactions":[{"id":1644347,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":94337,"kind":"organization","name":"Vida Ventures, LLC","position":1,"cik":"0001724489","reported_name":"Vida Ventures, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26880,"kind":"organization","name":"Vida Ventures GP III, L.L.C.","position":2,"cik":"0001855502","reported_name":"Vida Ventures GP III, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26881,"kind":"organization","name":"Vida Ventures III, L.P.","position":3,"cik":"0001855504","reported_name":"Vida Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26882,"kind":"organization","name":"Vida Ventures III-A, L.P.","position":4,"cik":"0001855503","reported_name":"Vida Ventures III-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Redeemable Convertible Preferred Stock","published_at":"2024-02-15T00:04:56.000Z","date":"2024-02-12","kind":"exercise","planned":false,"acquired":false,"shares":7356162,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Vida Ventures, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Series A-1, Series A-2 and Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 1-for-4.5511 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Series A-1, Series A-2 and Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 1-for-4.5511 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Series A-1, Series A-2 and Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 1-for-4.5511 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares of the Issuer's Common Stock are held directly by Vida Ventures, LLC. Vida Ventures Advisors, LLC is the investment advisor to Vida Ventures, LLC. Dr. Arie Belldegrun, Leonard Potter and Dr. Fred E. Cohen, a member of the Issuer's board of directors, are the managing members of Vida Ventures Advisors, LLC, and may be deemed to share voting and dispositive power over the shares held by Vida Ventures, LLC, but each disclaims beneficial ownership of the shares held by Vida Ventures, LLC, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1616348},"source":{"system":"sec-edgar","filing":"0000950170-24-015479","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1855502/000095017024015479/ownership.xml","form_type":"4"}},{"id":1644346,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":94337,"kind":"organization","name":"Vida Ventures, LLC","position":1,"cik":"0001724489","reported_name":"Vida Ventures, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26880,"kind":"organization","name":"Vida Ventures GP III, L.L.C.","position":2,"cik":"0001855502","reported_name":"Vida Ventures GP III, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26881,"kind":"organization","name":"Vida Ventures III, L.P.","position":3,"cik":"0001855504","reported_name":"Vida Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26882,"kind":"organization","name":"Vida Ventures III-A, L.P.","position":4,"cik":"0001855503","reported_name":"Vida Ventures III-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-2 Redeemable Convertible Preferred Stock","published_at":"2024-02-15T00:04:56.000Z","date":"2024-02-12","kind":"exercise","planned":false,"acquired":false,"shares":8830901,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Vida Ventures, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Series A-1, Series A-2 and Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 1-for-4.5511 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Series A-1, Series A-2 and Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 1-for-4.5511 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Series A-1, Series A-2 and Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 1-for-4.5511 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares of the Issuer's Common Stock are held directly by Vida Ventures, LLC. Vida Ventures Advisors, LLC is the investment advisor to Vida Ventures, LLC. Dr. Arie Belldegrun, Leonard Potter and Dr. Fred E. Cohen, a member of the Issuer's board of directors, are the managing members of Vida Ventures Advisors, LLC, and may be deemed to share voting and dispositive power over the shares held by Vida Ventures, LLC, but each disclaims beneficial ownership of the shares held by Vida Ventures, LLC, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1940388},"source":{"system":"sec-edgar","filing":"0000950170-24-015479","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1855502/000095017024015479/ownership.xml","form_type":"4"}},{"id":1644345,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":94337,"kind":"organization","name":"Vida Ventures, LLC","position":1,"cik":"0001724489","reported_name":"Vida Ventures, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26880,"kind":"organization","name":"Vida Ventures GP III, L.L.C.","position":2,"cik":"0001855502","reported_name":"Vida Ventures GP III, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26881,"kind":"organization","name":"Vida Ventures III, L.P.","position":3,"cik":"0001855504","reported_name":"Vida Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26882,"kind":"organization","name":"Vida Ventures III-A, L.P.","position":4,"cik":"0001855503","reported_name":"Vida Ventures III-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 Redeemable Convertible Preferred Stock","published_at":"2024-02-15T00:04:56.000Z","date":"2024-02-12","kind":"exercise","planned":false,"acquired":false,"shares":4401771,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Vida Ventures, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Series A-1, Series A-2 and Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 1-for-4.5511 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Series A-1, Series A-2 and Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 1-for-4.5511 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Series A-1, Series A-2 and Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 1-for-4.5511 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares of the Issuer's Common Stock are held directly by Vida Ventures, LLC. Vida Ventures Advisors, LLC is the investment advisor to Vida Ventures, LLC. Dr. Arie Belldegrun, Leonard Potter and Dr. Fred E. Cohen, a member of the Issuer's board of directors, are the managing members of Vida Ventures Advisors, LLC, and may be deemed to share voting and dispositive power over the shares held by Vida Ventures, LLC, but each disclaims beneficial ownership of the shares held by Vida Ventures, LLC, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":967188},"source":{"system":"sec-edgar","filing":"0000950170-24-015479","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1855502/000095017024015479/ownership.xml","form_type":"4"}},{"id":1644344,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":94337,"kind":"organization","name":"Vida Ventures, LLC","position":1,"cik":"0001724489","reported_name":"Vida Ventures, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26880,"kind":"organization","name":"Vida Ventures GP III, L.L.C.","position":2,"cik":"0001855502","reported_name":"Vida Ventures GP III, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26881,"kind":"organization","name":"Vida Ventures III, L.P.","position":3,"cik":"0001855504","reported_name":"Vida Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26882,"kind":"organization","name":"Vida Ventures III-A, L.P.","position":4,"cik":"0001855503","reported_name":"Vida Ventures III-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-15T00:04:56.000Z","date":"2024-02-12","kind":"purchase","planned":false,"acquired":true,"shares":583,"price":22,"value":12826.0,"ownership":{"direct":false,"nature":"By Vida Ventures III-A, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares of the Issuer's Common Stock are held directly by Vida Ventures III-A, L.P. (\"Vida III-A\"). Vida III GP is the general partner of Vida III-A. Vida III GP disclaims beneficial ownership of the securities held by Vida III-A, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary interest therein, if any."}],"balance_after":583,"source":{"system":"sec-edgar","filing":"0000950170-24-015479","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1855502/000095017024015479/ownership.xml","form_type":"4"}},{"id":1644343,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":94337,"kind":"organization","name":"Vida Ventures, LLC","position":1,"cik":"0001724489","reported_name":"Vida Ventures, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26880,"kind":"organization","name":"Vida Ventures GP III, L.L.C.","position":2,"cik":"0001855502","reported_name":"Vida Ventures GP III, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26881,"kind":"organization","name":"Vida Ventures III, L.P.","position":3,"cik":"0001855504","reported_name":"Vida Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26882,"kind":"organization","name":"Vida Ventures III-A, L.P.","position":4,"cik":"0001855503","reported_name":"Vida Ventures III-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-15T00:04:56.000Z","date":"2024-02-12","kind":"purchase","planned":false,"acquired":true,"shares":252553,"price":22,"value":5556166.0,"ownership":{"direct":false,"nature":"By Vida Ventures III, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares of the Issuer's Common Stock are held directly by Vida Ventures III, L.P. (\"Vida III\"). Vida Ventures GP III, L.L.C. (\"Vida III GP\") is the general partner of Vida III. Vida III GP disclaims beneficial ownership of the securities held by Vida III, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary interest therein, if any."}],"balance_after":252553,"source":{"system":"sec-edgar","filing":"0000950170-24-015479","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855502/000095017024015479/ownership.xml","form_type":"4"}},{"id":1644342,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":94337,"kind":"organization","name":"Vida Ventures, LLC","position":1,"cik":"0001724489","reported_name":"Vida Ventures, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26880,"kind":"organization","name":"Vida Ventures GP III, L.L.C.","position":2,"cik":"0001855502","reported_name":"Vida Ventures GP III, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26881,"kind":"organization","name":"Vida Ventures III, L.P.","position":3,"cik":"0001855504","reported_name":"Vida Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":26882,"kind":"organization","name":"Vida Ventures III-A, L.P.","position":4,"cik":"0001855503","reported_name":"Vida Ventures III-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-15T00:04:56.000Z","date":"2024-02-12","kind":"exercise","planned":false,"acquired":true,"shares":4523924,"ownership":{"direct":false,"nature":"By Vida Ventures, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's Common Stock received upon conversion of shares of the reported series of preferred stock on a 1-for-4.5511 basis without payment of further consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of the Issuer's Common Stock received upon conversion of shares of the reported series of preferred stock on a 1-for-4.5511 basis without payment of further consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares of the Issuer's Common Stock are held directly by Vida Ventures, LLC. Vida Ventures Advisors, LLC is the investment advisor to Vida Ventures, LLC. Dr. Arie Belldegrun, Leonard Potter and Dr. Fred E. Cohen, a member of the Issuer's board of directors, are the managing members of Vida Ventures Advisors, LLC, and may be deemed to share voting and dispositive power over the shares held by Vida Ventures, LLC, but each disclaims beneficial ownership of the shares held by Vida Ventures, LLC, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":4523924,"source":{"system":"sec-edgar","filing":"0000950170-24-015479","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855502/000095017024015479/ownership.xml","form_type":"4"}},{"id":3381618,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":94337,"kind":"organization","name":"Vida Ventures, LLC","position":1,"cik":"0001724489","reported_name":"Vida Ventures, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2019-11-04T19:04:44.000Z","date":"2019-11-04","kind":"exercise","acquired":false,"shares":778468,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Series B Convertible Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Series B Convertible Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Series B Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Series B Convertible Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock, par value $0.001 per share","underlying_shares":778468},"source":{"system":"sec-edgar","filing":"0001104659-19-059645","document":"tm1921748d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1720725/000110465919059645/tm1921748d1_4.xml","form_type":"4"}},{"id":3381617,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":94337,"kind":"organization","name":"Vida Ventures, LLC","position":1,"cik":"0001724489","reported_name":"Vida Ventures, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2019-11-04T19:04:44.000Z","date":"2019-11-04","kind":"purchase","acquired":true,"shares":185000,"price":16,"value":2960000.0,"ownership":{"direct":true},"balance_after":963468,"source":{"system":"sec-edgar","filing":"0001104659-19-059645","document":"tm1921748d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1720725/000110465919059645/tm1921748d1_4.xml","form_type":"4"}},{"id":3381616,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":94337,"kind":"organization","name":"Vida Ventures, LLC","position":1,"cik":"0001724489","reported_name":"Vida Ventures, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2019-11-04T19:04:44.000Z","date":"2019-11-04","kind":"exercise","acquired":true,"shares":778468,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Series B Convertible Preferred Stock had no expiration date."}],"balance_after":778468,"source":{"system":"sec-edgar","filing":"0001104659-19-059645","document":"tm1921748d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720725/000110465919059645/tm1921748d1_4.xml","form_type":"4"}},{"id":3968979,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":94337,"kind":"organization","name":"Vida Ventures, LLC","position":1,"cik":"0001724489","reported_name":"Vida Ventures, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120174,"kind":"organization","name":"VV Manager LLC","position":2,"cik":"0001735804","reported_name":"VV Manager LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2018-04-04T20:24:00.000Z","date":"2018-04-02","kind":"exercise","acquired":false,"shares":395845,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Upon closing of the Issuer's initial public offering, each share of preferred stock was automatically converted into one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Upon closing of the Issuer's initial public offering, each share of preferred stock was automatically converted into one share of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Upon closing of the Issuer's initial public offering, each share of preferred stock was automatically converted into one share of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held of record by Vida Ventures, LLC (\"Vida\"). VV Manager, LLC is the mananging member of Vida. As a result, VV Manager, LLC may be deemed to beneficially own the securities held by Vida. VV Manager, LLC is managed by five directors, each of who disclaim beneficial ownership over the securities held of record by Vida except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":395845},"source":{"system":"sec-edgar","filing":"0000899243-18-009441","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924318009441/doc4.xml","form_type":"4"}},{"id":3968978,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":94337,"kind":"organization","name":"Vida Ventures, LLC","position":1,"cik":"0001724489","reported_name":"Vida Ventures, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120174,"kind":"organization","name":"VV Manager LLC","position":2,"cik":"0001735804","reported_name":"VV Manager LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-04-04T20:24:00.000Z","date":"2018-04-02","kind":"purchase","acquired":true,"shares":375000,"price":16,"value":6000000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held of record by Vida Ventures, LLC (\"Vida\"). VV Manager, LLC is the mananging member of Vida. As a result, VV Manager, LLC may be deemed to beneficially own the securities held by Vida. VV Manager, LLC is managed by five directors, each of who disclaim beneficial ownership over the securities held of record by Vida except to the extent of their pecuniary interest therein."}],"balance_after":770845,"source":{"system":"sec-edgar","filing":"0000899243-18-009441","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924318009441/doc4.xml","form_type":"4"}},{"id":3968977,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":94337,"kind":"organization","name":"Vida Ventures, LLC","position":1,"cik":"0001724489","reported_name":"Vida Ventures, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120174,"kind":"organization","name":"VV Manager LLC","position":2,"cik":"0001735804","reported_name":"VV Manager LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-04-04T20:24:00.000Z","date":"2018-04-02","kind":"exercise","acquired":true,"shares":395845,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held of record by Vida Ventures, LLC (\"Vida\"). VV Manager, LLC is the mananging member of Vida. As a result, VV Manager, LLC may be deemed to beneficially own the securities held by Vida. VV Manager, LLC is managed by five directors, each of who disclaim beneficial ownership over the securities held of record by Vida except to the extent of their pecuniary interest therein."}],"balance_after":395845,"source":{"system":"sec-edgar","filing":"0000899243-18-009441","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000089924318009441/doc4.xml","form_type":"4"}}]}